A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer-Reference-Cited by-同舟云学术

A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer

Published:2020-04-01 Issue:4 Volume:30 Page:501-518
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Oh Ji Min¹²,Baek Se Hwan¹²,Gangadaran Prakash¹²³,Hong Chae Moon¹²,Rajendran Ramya Lakshmi¹²³,Lee Ho Won¹²,Zhu Liya¹²,Gopal Arunnehru¹²,Kalimuthu Senthilkumar¹²,Jeong Shin Young¹²,Lee Sang-Woo¹²,Lee Jaetae¹²,Ahn Byeong-Cheol¹²³

Affiliation:

1. Department of Nuclear Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

2. Department of Nuclear Medicine, Kyungpook National University Hospital, Daegu, Republic of Korea.

3. BK21 Plus KNU Biomedical Convergence Program, Department of Biomedical Science, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2018.0626

Reference45 articles.

1. Tyrosine kinase inhibitors for the therapy of anaplastic thyroid cancer

2. Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment

3. Genetic Alterations Involved in the Transition from Well-Differentiated to Poorly Differentiated and Anaplastic Thyroid Carcinomas

4. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recapitulating thyroid cancer histotypes through engineering embryonic stem cells;Nature Communications;2023-03-11

2. Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer;Advanced Science;2022-12

3. Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC);Endocrine;2022-06-29

4. Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii;Pediatric Hematology and Oncology;2022-05-03

5. Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers;Cancers;2022-03-31